SDS Biotech K.K. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2013
2014
2016
2017
2018
2019
Net Income before Extraordinaries
1,010
1,376
1,660
226
467
574
Depreciation, Depletion & Amortization
470
481
593
447
278
155
Other Funds
225
535
1,071
520
1,856
200
Funds from Operations
1,255
1,322
1,183
741
1,667
929
Changes in Working Capital
259
281
1,618
746
720
167
Net Operating Cash Flow
1,515
1,041
435
5
2,387
762
Capital Expenditures
243
253
321
299
232
Purchase/Sale of Investments
-
1,275
4
-
8
Net Investing Cash Flow
1,871
1,517
354
260
2,467
Cash Dividends Paid - Total
156
156
157
215
196
Issuance/Reduction of Debt, Net
1,110
1,306
1,131
4
1,045
Net Financing Cash Flow
1,257
1,150
974
220
850
Net Change in Cash
1,601
720
174
528
779
Free Cash Flow
1,297
803
699
285
2,168
Net Assets from Acquisitions
1,630
-
20
-
2,244
Other Sources
-
2
12
-
39
Change in Capital Stock
9
-
-
-
-
Exchange Rate Effect
13
46
11
43
9
About SDS Biotech
View Profile
